The Breast Pathology Fellowship is a one-year program that provides a thorough exposure to diagnostic surgical pathology of the breast as well as insight into the multidisciplinary management of breast disease. The fellowship is accredited by the ACGME.
The main objective of the program is to provide the fellow with proficient diagnostic skills, in-depth understanding of the implications of pathologic diagnoses in the management of breast cancer patients, and a unique translational research experience. The program also allows the fellow to understand the histopathologic entities that constitute benign and malignant breast disease and be able to identify morphologic features of non-proliferative, and atypical benign breast lesions and their associated risk for the future development of invasive breast cancer.
The breast fellow will spend time in the frozen section laboratory for intraoperative evaluation of breast surgical specimens, grossing of cases and touch imprints of breast and lymph nodes. The fellow will look at slides of all these cases, generate reports and sign the cases with a breast pathology faculty and will also become an expert in reporting breast cases.
There is extensive emphasis on a multidisciplinary approach to specimen evaluations, and the fellow interacts closely with breast surgeons and radiologists in the evaluation of specimens. During mandatory rotations, the breast fellow learns the protocols employed for immunohistochemical and in situ hybridization studies and all aspects of breast cytology.
It is expected that the breast pathology fellow will develop sufficient expertise to classify premalignant lesions, invasive carcinoma and the clinical implications of these diagnosis. The use of immunohistochemical markers such as estrogen and progesterone receptor and HER2/neu (including the use of fluorescent in situ hybridization analysis) and their impact on breast cancer treatment options are addressed.
The breast fellow is also exposed to newer techniques that promise to impact pathologic diagnosis and treatment of breast cancer, including cDNA microarrays, laser capture microdissection and breast cancer tissue arrays. The fellow also concentrates on signing out breast pathology consultation cases and outside consultation cases from a very active breast clinic and regional/national consultation service respectively, with a staff pathologist.
The fellow discusses the cases at the Multidisciplinary Breast Care Clinic Conference, which provides a unique learning experience. The research aspect of the fellowship is tailored to meet the individual fellow’s interest. He/she has the opportunity to conduct clinical projects, and/or translational research projects or spend time in a basis research laboratory focusing on breast cancer-related basic science research.
Candidates must be board-certified or eligible for certification in anatomic pathology or AP/CP.
Please check complete GME Eligibility Requirements prior to applying.
July 15, 24 months prior to the start of the training year.
Commensurate with the candidate’s level of training.
Constance Albarracin, M.D., Ph.D.
Program Director, Breast Pathology Fellowship
MD Anderson Cancer Center
Department of Pathology, Unit 085
1515 Holcombe Blvd.
Houston, TX 77030
For inquiries, please contact:
Kareen E. Chin
For inquiries on elective rotations, please email:
For inquiries on observerships, please email:
Verification of training
Requests for verification should be sent to:
MD Anderson Cancer Center is committed to encouraging good health and staying true to our mission to end cancer. If you are applying for a GME fellowship or residency program starting on or after July 1, 2016, please be advised that MD Anderson will have instituted a tobacco-free hiring process as part of its efforts to achieve these goals. If you are offered an appointment, you will be subject to a Pre-Employment Drug Screen for tobacco compounds in compliance with applicable state laws. If you do not pass the urine drug screening which includes testing for tobacco compounds, you CANNOT be appointed at MD Anderson. Should you fail to meet this contingency, MD Anderson will withdraw your offer of appointment for the academic year. You may reapply for the following academic year, but there are no guarantees that you will be offered a position as many of our programs are already filled for several years out.